Please assess the completion status of the following clinical trial:

Trial Title: A Study to Assess the Bioequivalence of Aprepitant and Fosaprepitant and the Effect of Food on Aprepitant Bioavailability (0869-165)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Subject is in good health~* Subject is a nonsmoker~* Subject is willing to comply with the study restrictions~Exclusion Criteria:~* Subject has a history of any illness that might confound the results of the study or might make participation in the study unsafe~* Subject has a history of stroke, seizures, or major neurological disorder~* Subject has a history of cancer~* Subject consumes more than two alcoholic drinks per day~* Subject consumes more than three caffeinated beverages daily

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): aprepitant 165 mg
- 2 (Type: ACTIVE_COMPARATOR): aprepitant 185 mg
- 3 (Type: EXPERIMENTAL): fosaprepitant 150 mg
- 4 (Type: EXPERIMENTAL): aprepitant with food

Based on this trial design, predict the completion outcome and termination type (if applicable).